ACC Scientific Session - New Orleans

Richmond Pharmacology is pleased to attend the American College of Cardiology (ACC) Scientific Session in New Orleans, USA, 28–30 March 2026

This global meeting brings together leading cardiologists, researchers, and industry innovators to advance cardiovascular science and improve patient care through cutting-edge research, clinical insights, and collaborative solutions.

Representing Richmond Pharmacology

Jörg Taubel, Chief Executive Officer

We look forward to connecting with attendees to discuss Richmond’s expertise in:

• Innovations in cardiovascular drug development

• Clinical trial design for complex cardiac conditions

• Regulatory pathways for novel therapies

• Patient-centric approaches and recruitment strategies

• Collaboration between academia, industry, and regulators

Connect With Us

If you are attending ACC Scientific Session 2026 and would like to explore partnership or development opportunities email us at:

📧 fasteranswers@richmondpharmacology.com

‍